The following is from The Vaccine Reaction. In 2014, the U.S. Food and Drug Administration (FDA) awarded a grant of nearly $325,000 to the Children’s Hospital of Philadelphia (CHOP) to study the side effects of the osmotive laxative MiraLAX in […]